clinical suspicion of prostate cancer from 2015 to 2018 was performed. Patients who underwent prostatectomy for prostate cancer were identified and further analysis of their imaging and pathology findings were done. MRI was read by fellowship trained radiologist. Pathology was reviewed by fellowship trained pathologist.
INTRODUCTION AND OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy (TBx) are increasingly being used in the diagnosis of prostate cancer (PCa). Ommitance of transrectal ultrasound (TRUS)-guided systematic biopsy (SBx) in men with a positive prebiopsy mpMRI undergoing TBx remains controversial. In this study we evaluated the additional clinical relevance of SBx in men with a positive prebiopsy mpMRI undergoing TBx for PCa detection, Gleason grading and PCa localization.
METHODS: 255 consecutive men with a prebiopsy positive mpMRI (PI-RADSv2: Prostate Imaging Reporting and Data System version 2 !3) and no prior diagnosis of PCa underwent 12-core SBx and subsequent MRI-TRUS fusion TBx in two institutions between 2015 and 2018. Detection rates for clinically significant (cs)PCa (Gleason score (GS)!3þ4) and insignificant PCa (GS[3þ3) for TBx and SBx were compared with the McNemar test. We determined the number of missed and GS undergraded csPCa on TBx and SBx. We evaluated the role of MRI reading and lesion targeting for missed csPCa in a TBx pathway using MRI data and positive SBx locations. We compared GSs and tumor core involvement and determined positive csPCa SBx and TBx core locations within each prostate to assess the role of TBx and SBx in detection of multifocal PCa.
RESULTS: Of the 160 men with a positive biopsy, 126 men (79%) were diagnosed with csPCa (GS!3þ4) and 34 men (21%) CONCLUSIONS: We identified BMI as an independent risk factor for the need for IVC resection during thrombectomy of RCC with tumor thrombus. It warrants more careful preoperative preparation for the vascular resection and/or reconstruction in patients with higher BMI.
